about
Kawasaki Disease: A Clinician's UpdateApplication of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease.A heart-breaking case of fever and rashKawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system".Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmasAntithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Profiles of responses of immunological factors to different subtypes of Kawasaki disease.Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.Clinical outcome of patients with refractory Kawasaki disease based on treatment modalitiesCoronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.Concurrent adrenal neuroblastoma and kawasaki disease: a report of a rare caseSuperantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients.Acetylsalicylic acid for children with Kawasaki disease.Co-morbidity of Kawasaki disease.A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.L’acide acétylsalicylique pour les enfants atteints de la maladie de Kawasaki.The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.Controversies in diagnosis and management of Kawasaki disease.Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children.Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.A 3-month-old infant with atypical Kawasaki disease.
P2860
Q26998791-21269249-978A-4970-A744-EDAE03F81490Q30446491-51AECE31-A059-4494-8794-FC72C3D858D8Q34071462-C6BE7141-AA9A-4DB1-8F7C-E97451CDC351Q34253124-680EFA07-D57E-4F5C-8DFF-ACB0E890ADDAQ35184950-B03C1CA3-0F9D-4614-B6F1-E455E5B71583Q35752608-290C5753-FC00-46BD-9EA4-8554B87E555FQ35819600-5C08F7F0-AEC1-43B7-87FD-DBC28D2C1D60Q36660337-4C2E7F1A-DB62-47DB-AD9B-A11E92134A3BQ37239530-91ED5B0F-E58A-4405-BFD8-A99503F413C9Q37364378-9D73C664-3D83-4D82-8538-55E4A52C6292Q38087960-A3825790-15C3-4356-BEDA-47B55F744374Q39447395-8F34C86D-3702-45FC-BB6C-E8BD63B37D54Q40043358-D71F0D70-19AC-4A3A-8F5E-2FDD24880293Q40306788-9048EE3B-ED31-41D6-B610-B6C02C28525CQ40311553-8D80F7F6-E569-4CD4-8533-D2A2E58DDA9FQ41379432-AB45BDBA-BAA0-45BF-B940-81C2A5EE46F7Q45909002-D37080FE-FB41-4B05-A7C8-900054D7D5B6Q47134975-ABFC8860-CF4A-4023-A201-5F60B2ED6C9EQ49873428-49BF3C07-BED0-4599-835A-29A53173C69AQ50218487-3734E1AA-AF4E-4BA6-82CD-241CB309F5D2Q53090633-67A77825-22A7-4C83-A7A3-8A7CBE12A4CBQ54144614-C83B0ED1-B811-4FDF-9A4B-D9D1175373D6Q54198415-025FEC15-9D1F-4C14-9778-346CF06D8941Q54276724-2EDAC124-448F-47D7-B0F4-2F42867BFD4EQ55339665-AF7B5272-32C7-486A-9E40-E6381ADB3D2F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Pathogenesis and management of Kawasaki disease
@ast
Pathogenesis and management of Kawasaki disease
@en
Pathogenesis and management of Kawasaki disease
@en-gb
Pathogenesis and management of Kawasaki disease
@nl
type
label
Pathogenesis and management of Kawasaki disease
@ast
Pathogenesis and management of Kawasaki disease
@en
Pathogenesis and management of Kawasaki disease
@en-gb
Pathogenesis and management of Kawasaki disease
@nl
prefLabel
Pathogenesis and management of Kawasaki disease
@ast
Pathogenesis and management of Kawasaki disease
@en
Pathogenesis and management of Kawasaki disease
@en-gb
Pathogenesis and management of Kawasaki disease
@nl
P2860
P3181
P356
P1476
Pathogenesis and management of Kawasaki disease
@en
P2093
Anne H Rowley
Stanford T Shulman
P2860
P304
P3181
P356
10.1586/ERI.09.109
P407
P577
2010-02-01T00:00:00Z